Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia".

ABSTRACT: LB100 does not sensitize CML stem cells to tyrosine kinase inhibitor-induced apoptosis.

SUBMITTER: Perrotti D 

PROVIDER: S-EPMC7402218 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature